Nina M. Lauridsen-Harder

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.

Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.

Journal: Diabetes, obesity & metabolism

Published: December 22, 2025

Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial.

Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial.

Journal: The lancet. Diabetes & endocrinology

Published: June 05, 2025

Response to "Weight-loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk".

Response to "Weight-loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk".

Journal: Obesity (Silver Spring, Md.)

Published: May 19, 2025

Liraglutide for Children 6 to <12 Years of Age with Obesity. Reply.

Liraglutide for Children 6 to <12 Years of Age with Obesity. Reply.

Journal: The New England journal of medicine

Published: May 07, 2025

Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study.

Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study.

Journal: Diabetes care

Published: April 08, 2025

Real-world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases.

Real-world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases.

Journal: Diabetes, obesity & metabolism

Published: January 16, 2025

Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.

Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.

Journal: The New England journal of medicine

Published: September 11, 2024

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.

Journal: Obesity (Silver Spring, Md.)

Published: August 13, 2024

Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database.

Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database.

Journal: Diabetes, obesity & metabolism

Published: February 14, 2023

Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo-controlled SCALE Teens trial.

Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo-controlled SCALE Teens trial.

Journal: Pediatric obesity

Published: November 09, 2022

Intermittent Standing but not a Moderate Exercise Bout Reduces Postprandial Glycemia.

Intermittent Standing but not a Moderate Exercise Bout Reduces Postprandial Glycemia.

Journal: Medicine and science in sports and exercise

Published: June 23, 2017

The effect of alternate-day caloric restriction on the metabolic consequences of 8 days of bed rest in healthy lean men: a randomized trial.

The effect of alternate-day caloric restriction on the metabolic consequences of 8 days of bed rest in healthy lean men: a randomized trial.

Journal: Journal of applied physiology (Bethesda, Md. : 1985)

Published: September 19, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026